Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment

MLA

Anna Cichocka, et al. “Relationship between HER2 Gene Status and Selected Potential Biological Features Related to Trastuzumab Resistance and Its Influence on Survival of Breast Cancer Patients Undergoing Trastuzumab Adjuvant Treatment.” OncoTargets and Therapy, vol. 11, Aug. 2018, pp. 4525–35. EBSCOhost, https://doi.org/10.2147/ott.s166983.

APA

Anna Cichocka, Agnieszka Harazin-Lechowska, Agnieszka Adamczyk, Małgorzata Domagała-Haduch, Aleksandra Grela-Wojewoda, Joanna Niemiec, Aleksandra Ambicka, Kaja Majchrzyk, Anna Janecka-Widła, Janusz Ryś, & Anna Kruczak. (2018). Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment. OncoTargets and Therapy, 11, 4525–4535. https://doi.org/10.2147/ott.s166983

Chicago

Anna Cichocka, Agnieszka Harazin-Lechowska, Agnieszka Adamczyk, Małgorzata Domagała-Haduch, Aleksandra Grela-Wojewoda, Joanna Niemiec, Aleksandra Ambicka, et al. 2018. “Relationship between HER2 Gene Status and Selected Potential Biological Features Related to Trastuzumab Resistance and Its Influence on Survival of Breast Cancer Patients Undergoing Trastuzumab Adjuvant Treatment.” OncoTargets and Therapy 11 (August): 4525–35. doi:10.2147/ott.s166983.